Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04322162 · ClinicalTrials.gov registry record · NA
Addressing Sleep Apnea Post-Stroke/TIA
A NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT04322162: Active NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by VA Office of Research and Development.
NCT04322162 is a NA study of Obstructive Sleep Apnea and Ischemic Stroke that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 6 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04322162, a NA study of Obstructive Sleep Apnea and Ischemic Stroke, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
Effectively identifying and treating risk factors for ischemic stroke and transient ischemic attack (TIA) is important to patients, their family members, and healthcare systems. While obstructive sleep apnea (OSA) is a known risk factor for stroke and TIA that is present in more than 70% of stroke/TIA survivors, testing for OSA is infrequently performed for patients and within healthcare systems. The Addressing Sleep Apnea Post-Stroke/TIA (ASAP) study intends to improve rates of guideline-recommended OSA testing and treatment through local quality improvement initiatives (QI) conducted within and across 6 VA Medical Centers. ASAP will also determine the impact of these local QI initiatives on rates of OSA diagnosis, OSA treatment, recurrent vascular events, and hospital readmissions.
Conditions Studied
Interventions
- OTHER ASAP Intervention Quality Improvement Protocol
Study Locations (2)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-04-02 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What the registry record for NCT04322162 still lists
NCT04322162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which ASAP Intervention Quality Improvement Protocol is the first listed.
NCT04322162 reports a single indexed study location in Connecticut, Indiana.
Frequently Asked Questions
What is clinical trial NCT04322162 about?
NCT04322162 is a clinical study titled "Addressing Sleep Apnea Post-Stroke/TIA". Effectively identifying and treating risk factors for ischemic stroke and transient ischemic attack (TIA) is important to patients, their family members, and healthcare systems. While obstructive sleep apnea (OSA) is a known risk factor for stroke and TIA that is present in more than 70% of stroke/T...
What is the current status of trial NCT04322162?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2020-04-02. Estimated completion is 2024-07-31.
What conditions does trial NCT04322162 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Ischemic Stroke, Transient Ischemic Attack (TIA).
What interventions are being tested in trial NCT04322162?
The interventions under investigation include: ASAP Intervention Quality Improvement Protocol (OTHER).
Who is sponsoring clinical trial NCT04322162?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04322162 being conducted?
This trial has 2 study locations across Connecticut, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04322162's enrollment target sits among peer trials
6 155th of 155 higher than 1 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI